Acute Coronary Syndrome (ACS) |
| See also (bottom of page): |
| • General Mx Principles - Special Notes • ACS - Special Notes |
| Consider the spectrum of illnesses within ACS | |
| Acute Coronary Syndrome - General Management Principles |
| Assess for requirements for: |
| • Pain relief/nitrates • Antiplatelet Rx • Control of hypertension |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| General Mx Principles - Special Notes |
| GTN is a potent venodilator that can decrease venous return therefore decreasing right ventricular (RV) filing and fibre stretch with a reduction in cardiac output. The use of GTN is contraindicated in Inferior and RV infarcts. |
| Up to 50% of Inferior AMIs have RV involvement and cannot compensate to a drop in venous return due to myocardial insufficiency. |
| Signs of an Inferior AMI include ST elevation in leads II and III. Bradycardia is not unusual in an Inferior AMI due to the involvement of the right coronary artery and the SA / AV nodes. |
| Nitrates are contraindicated in bradycardia (HR < 50) due to the Pt’s inability to compensate to a decrease in venous return by increasing HR to improve cardiac output. - C.O. = HR x SV |
| ACS - Special Notes |
| Acute Coronary Syndrome (ACS) is a spectrum of illnesses including: Unstable Angina, Non-ST Elevation Myocardial Infarction (NSTEMI) and ST-Elevation Myocardial Infarction (STEMI) |
| Not all Pts with ACS will present with pain, e.g. diabetic Pts, atypical presentations, elderly Pts. |
| The absence of ischaemic signs on the ECG does not exclude AMI. AMI is diagnosed by presenting history, serial ECGs and serial blood enzyme tests |
| Suspected ACS related pain that has spontaneously resolved warrants investigation in hospital. |
| The goal of management in ACS is to resolve pain completely if safe to do so. This reduces cardiac workload. |
| The IM route of administration is relatively contraindicated in ACS if Pt is eligible for thrombolysis |
| Current evidence suggests transport to a PCI-enabled facility improves Pt outcomes in STEMI transport time <90mins. |